Epstein’s pal attempts a biotech comeback, and Prasad exits the FDA
On this week's The Readout LOUD podcast: A friend of Jeffrey Epstein attempts a biotech comeback, and (another) Prasad FDA exit.
Browse the full archive, newest first.
On this week's The Readout LOUD podcast: A friend of Jeffrey Epstein attempts a biotech comeback, and (another) Prasad FDA exit.
Strategic angle: US Defense Secretary Hegseth has stated that Iran's leader is likely disfigured and may not make public appearances.
Strategic angle: Experts warn of ‘attack on Americans’ lungs’ from cuts to health programs and environmental rollbacks.
Strategic angle: The smaller Ineos Fusilier project is back on track, with plans for electric and range-extender versions still under consideration.
Strategic angle: MacKenzie Scott and many of America's richest are absent from the latest Philanthropy 50 ranking.
Strategic angle: WTI crude saw its biggest weekly gain since the 1980s last week.
Strategic angle: The weapons approved are part of an $11 billion arms package announced by Washington in December.
Strategic angle: The subject has polarised India for long, though some states and private companies offer menstrual leaves.
Strategic angle: The team behind the Boxster and Cayman EVs is 'doing a great job.'